Tranexamic Acid Injection is an anti-fibrinolytic hemostatic drug, with tranexamic acid as the main component. It can competitively inhibit the binding of plasminogen to fibrin, prevent fibrin dissolution, thereby exerting hemostatic effect. It is suitable for the treatment of various bleeding caused by acute or chronic, localized or systemic primary fibrinolytic hyperfunction, such as postpartum hemorrhage, surgical bleeding, traumatic bleeding, upper gastrointestinal bleeding, etc. It can also be used as an adjuvant treatment for bleeding after tooth extraction or oral surgery in hemophilia patients. This injection is administered by intravenous injection, and the drug can quickly enter the blood circulation, rapidly exerting hemostatic effect, being a commonly used high-efficiency hemostatic drug in clinical practice.
